ZERAFEN

This brand name is authorized in Nigeria.

Active ingredients

The drug ZERAFEN contains one active pharmaceutical ingredient (API):

1
UNII WK2XYI10QM - IBUPROFEN
 

Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.

 
Read more about Ibuprofen

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-0447 Caplet ZERAFEN 400 CAPLET TAB 400 mg 38 CMS-PP-272485 ZERAFEN 400 CAPLET IBUPROFEN B.P. 400MG Ibuprofen B.P. 400mg, Magnesium stearate, Talc powder, Corn starch, Methy paraben B4-0447 Drugs MUSCULO-SKELETAL SYSTEM Nigerian Products 2x10 Prescription Only Medicine (POM) 6/30/2022 KCH CONSUMER HEALTHCARE LIMITED, 2B, KWAME NKRUMAH LANE, CROWN ESTATE LEKKI EPE EXPRESSWAY 8032317925 Kchconsumer@gmail.com KCH Consumer Healthcare Ltd., Plot 1-6 KCH Close, Off Atlantic Hall Expressway, Poka, Lekki Free Trade Zone, Epe, Lagos., Nigeria 06/07/2023
B4-0466 Tablet ZERAFEN 200 TAB 200 mg 10 X 20 37 CMS-PP-272480 ZERAFEN 200 IBUPROFEN B.P. 200MG Ibuprofen B.P.200mg, Magnesium stearate, Talc powder, Corn starch, Methy paraben B4-0466 Drugs MUSCULO-SKELETAL SYSTEM Nigerian Products 1x20 POM 1 6/30/2022 KCH CONSUMER HEALTHCARE LIMITED, 2B, KWAME NKRUMAH LANE, CROWN ESTATE LEKKI EPE EXPRESSWAY 8032317925 Kchconsumer@gmail.com KCH Consumer Healthcare Ltd., Plot 1-6 KCH Close, Off Atlantic Hall Expressway, Poka, Lekki Free Trade Zone, Epe, Lagos., Nigeria 06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M01AE01 Ibuprofen M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-0447, B4-0466

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.